Bioluminescence Imaging in an EAE Mouse Model
JoVE Encyclopedia of Experiments
Neuroscience
0 views • 2:27 min • May 29th, 2025
Loading...
Overview
This article describes a method for in vivo imaging of inflammation in mice with experimental autoimmune encephalomyelitis (EAE). The technique utilizes bioluminescent substrates to visualize inflammation in the optic nerve and brain.
Key Study Components
Area of Science
- Neuroscience
- Immunology
- In vivo imaging
Background
- Experimental autoimmune encephalomyelitis (EAE) is a model for studying neuroinflammation.
- Bioluminescence imaging allows for real-time visualization of inflammatory processes.
- Understanding inflammation in EAE can provide insights into multiple sclerosis.
- Imaging techniques can help assess the severity of inflammation in the optic nerve and brain.
Purpose of Study
- To develop a reliable method for imaging inflammation in EAE mice.
- To evaluate the effectiveness of bioluminescent substrates in detecting inflammation.
- To provide a protocol for capturing bioluminescent signals in vivo.
Methods Used
- Use of anesthetized mice with EAE for imaging.
- Injection of bioluminescent substrate intraperitoneally.
- Imaging performed with a camera and software to capture bioluminescent signals.
- Regular time interval imaging to monitor inflammation.
Main Results
- Bioluminescent signals indicate the level of inflammation in the optic nerve and brain.
- Images show varying intensities of inflammation, with blue indicating mild and red indicating severe inflammation.
- Effective imaging protocol established for monitoring inflammation over time.
- Demonstrated the feasibility of using bioluminescence for in vivo studies of neuroinflammation.
Conclusions
- The method provides a valuable tool for studying neuroinflammation in EAE models.
- Bioluminescence imaging can enhance understanding of inflammatory processes in the central nervous system.
- This approach may contribute to the development of therapeutic strategies for neuroinflammatory diseases.
Frequently Asked Questions
What is experimental autoimmune encephalomyelitis (EAE)?
EAE is an animal model used to study multiple sclerosis and neuroinflammation.
How does bioluminescence imaging work?
It involves injecting a substrate that emits light when it interacts with inflammation-specific enzymes.
What are the benefits of using this imaging method?
It allows for real-time monitoring of inflammation and can provide insights into disease progression.
What does the color coding in the images signify?
Blue indicates mild inflammation, while red indicates severe inflammation.
What is the significance of the optic nerve in this study?
The optic nerve is closely monitored as it is affected by inflammation in EAE, making it a key area for imaging.
How long should the mice be under anesthesia during imaging?
Mice should be kept under 2 to 2.5% isoflurane anesthesia throughout the imaging procedures.
Executive Industry Relevance
Bioluminescence imaging enables real-time, non-invasive monitoring of neuroinflammation in preclinical models, supporting target validation and mechanistic de-risking in CNS drug discovery. The method provides quantitative, longitudinal data on inflammatory burden, improving predictive confidence in early-stage therapeutic evaluation. This capability aids in prioritizing candidates with favorable neuroinflammatory profiles before advancing to costly later-stage studies.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Interrogates therapeutic hypotheses by visualizing inflammation-specific enzyme activity in vivo.
- Operational Value: Enables longitudinal tracking of target engagement and pathway modulation in the same animal.
- Predictive Value: Supports biological de-risking by correlating biomarker signals with disease severity.
Screening & Assay Development
- Scientific Value: Prepares validated disease-relevant systems for compound screening with built-in inflammation readouts.
- Operational Value: Standardizes imaging protocols for reproducible, quantitative bioluminescent outputs across studies.
- Scalability: Facilitates platform reuse for longitudinal monitoring in inducible neuroinflammatory models.
Translational & Preclinical Research
- Scientific Value: Aligns with translational biomarker strategies by linking optical signal intensity to histopathological inflammation.
- Operational Value: Bridges discovery and preclinical workflows through consistent, non-terminal imaging endpoints.
- Risk Mitigation: Informs go/no-go decisions by revealing off-target neuroinflammatory effects early.
Pipeline & Workflow Integration
The method integrates into the discovery continuum from target validation through preclinical efficacy testing, enabling iterative assessment of CNS-active compounds.
- Discovery Biology: Supports hypothesis testing by visualizing inflammation in anatomically defined regions like the optic nerve.
- Screening: Delivers assay-ready, reproducible bioluminescent signals for compound-induced modulation studies.
- Analytics: Generates time-resolved quantitative readouts that enable comparison of anti-inflammatory potency across candidates.
- Translational Research: Connects to preclinical validation via correlative imaging and endpoint biomarker alignment.
- Enterprise Reuse: Establishes a reusable imaging capability for multiple neuroinflammatory disease models.
Operational & Enterprise Impact
- Scientific Value: Enhances target validation confidence through direct visualization of mechanism-linked inflammation.
- Operational Value: Standardizes longitudinal imaging workflows, reducing variability in preclinical data generation.
- Strategic Value: Improves capital efficiency by enabling early detection of neuroinflammatory liabilities.
- Portfolio Impact: Supports risk-adjusted prioritization by identifying candidates with favorable CNS safety profiles.
Implementation Considerations
- Requires expertise in anesthesia management and intraperitoneal injection techniques for consistent substrate delivery.
- Depends on sensitive bioluminescence imaging systems and controlled environmental shielding to minimize background interference.
- Necessitates standardized protocols for image acquisition timing and signal quantification across study sites.
- Involves adaptation considerations when extending to other inflammation models or anatomical targets beyond the optic nerve.
- Limited by tissue depth and light absorption, which constrains signal detection in deep brain structures.
Biopharma FAQs
Why is null hypothesis testing important for validating inflammation targets in EAE?
Null hypothesis testing determines whether observed bioluminescent signals exceed background levels, confirming that inflammation-specific enzyme activity is driving the signal rather than nonspecific distribution. This statistical rigor supports target validation by establishing a significant difference between diseased and control conditions.
How does isolating the independent variable (disease state) improve target validation in neuroinflammation studies?
By comparing bioluminescent signals in EAE-induced mice versus healthy controls while holding substrate dose and imaging conditions constant, researchers isolate the effect of disease on inflammation-specific signaling. This control enables confident attribution of signal changes to the target biological process.
What quantitative dependent variable measurements does bioluminescence imaging enable for inflammation assessment?
The technique provides quantitative measurements of photon flux over time, allowing calculation of signal intensity, peak emission, and area under the curve as dependent variables. These metrics enable dose-response modeling and longitudinal tracking of inflammatory burden in preclinical studies.
Why are replication requirements critical for ensuring cross-functional reliability of inflammation imaging data?
Replication across animals, time points, and experimental runs ensures that bioluminescent signals are consistent and not due to procedural variability or animal-specific factors. This reliability is essential for generating defensible data that inform cross-functional go/no-go decisions in drug development.
What statistical analysis capabilities are required before implementing bioluminescence imaging in a discovery workflow?
Implementation requires the ability to perform longitudinal data analysis, including repeated measures ANOVA or mixed-effects modeling, to account for within-animal correlations over time. Additionally, threshold-based signal detection and background subtraction methods are needed to ensure accurate quantification of inflammation-specific bioluminescence.
08:47
Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues
Related Videos
0 Views
10:50
Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo
Related Videos
0 Views
08:17
Scoring Central Nervous System Inflammation, Demyelination, and Axon Injury in Experimental Autoimmune Encephalomyelitis
Related Videos
0 Views
12:19
In vitro and in vivo Bioluminescence Reporter Gene Imaging of Human Embryonic Stem Cells
Related Videos
0 Views
10:23
Using Luciferase to Image Bacterial Infections in Mice
Related Videos
0 Views
10:42
Bioluminescence Imaging of NADPH Oxidase Activity in Different Animal Models
Related Videos
0 Views
05:06
Bioluminescent Bacterial Imaging In Vivo
Related Videos
0 Views
02:02
Bioluminescence Imaging of Bacterial Infections in Mice
Related Videos
0 Views
02:12
Real-Time Imaging of Bacterial Infection in a Mouse Model Using Bioluminescence
Related Videos
0 Views
02:07
Bioluminescence Imaging to Track Bacterial Infection and Wound Healing in a Mouse Model
Related Videos
0 Views
Last updated: 18 July 2026